Related Experiment Video
Updated: May 24, 2026

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
Published on: October 27, 2023
Spondyloarthropathies: new directions in etiopathogenesis, diagnosis and treatment
Gregory Wilson1, Darcy D Folzenlogen
1University of Missouri School of Medicine, Division of Immunology and Rheumatology, USA. Wilsongj@health.missouri.edu
Abstract:
The spondyloarthropathies (SpA) are a group of inflammatory rheumatic diseases affecting the spine, peripheral joints and nonarticular structures. Often referred to as "seronegative" due to the absence of rheumatoid factor, SpA include ankylosing spondylitis (AS), reactive arthritis (ReA), enteropathic (IBD) associated arthritis, psoriatic arthritis (PsA), as well as undifferentiated, and juvenile SpA. A broad and overlapping spectrum of disease presentations creates difficulties in determining an initial diagnosis. In the last 10 years treatment options have expanded.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Degenerative Disc Disease ll: Pathophysiology
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Crohn's Disease
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease III: Medical Management